KRAS and pancreatic neoplasm: In lung cancer, double or multiple EGFR mutations were observed in CTCs of patients with non-small-cell lung cancer, which indicated CTC mutation heterogeneity.27, 28 In pancreatic cancer, the presence of various KRAS mutations in codons 12 and 13 in CTCs indicated heterogeneity.29